Remus Pharmaceuticals Ltd
NSE: REMUS BSE: 78788
₹746.90
(4.40%)
Wed, 13 May 2026, 09:33 am
Market Cap8.43B
PE Ratio26.26
Dividend0.14
Remus Pharmaceuticals Cashflow
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Deprecation and amortization | -1.06M | -1.75M | -1.55M | -4.77M | -11.20M | -18.70M |
| Accumulated depreciation, total | -1.51M | -3.26M | -4.81M | -9.45M | -18.20M | -25.70M |
| Cash from operating activities | 12.80M | 28.71M | 51.95M | 54.25M | 31.30M | 83.80M |
| Funds from operations | 9.80M | 11.69M | 35.74M | 86.99M | 255.70M | 415.30M |
| Net income (cash flow) | 8.12M | 10.26M | 34.34M | 85.03M | 205.20M | 290.70M |
| Depreciation & amortization (cash flow) | 1.06M | 1.75M | 1.55M | 4.77M | 11.20M | 18.70M |
| Depreciation/depletion | 1.06M | 1.75M | 1.55M | 4.64M | 11.00M | 18.60M |
| Amortization | — | — | — | 130.00K | 200.00K | 100.00K |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -2.20M | -3.65M | -11.94M | -31.92M | -57.20M | -76.80M |
| Changes in working capital | 3.00M | 17.03M | 16.20M | -32.74M | -224.40M | -331.50M |
| Cash from investing activities | -5.59M | -31.59M | -47.89M | -155.37M | -461.40M | -134.40M |
| Capital expenditures | -5.59M | -664.00K | -710.00K | -27.32M | -120.20M | -39.80M |
| Capital expenditures - fixed assets | -5.59M | -664.00K | -710.00K | -26.68M | -120.20M | -39.80M |
| Capital expenditures - other assets | — | — | — | -633.00K | — | — |
| Cash from financing activities | 869.00K | -804.00K | -872.00K | 120.01M | 419.50M | 75.30M |
| Free cash flow | 7.21M | 28.05M | 51.24M | 27.57M | -88.90M | 44.00M |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800